SMTI Sanara MedTech Inc.
Healthcare$22.93-1.04%ClosedMarket Cap: $210.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
28.70
P/S
1.98
EV/EBITDA
21.58
DCF Value
$59.91
FCF Yield
1.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
91.2%
Operating Margin
7.9%
Net Margin
-31.2%
ROE
-246.4%
ROA
-48.5%
ROIC
15.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $27.8M | 91.0% | $2.6M | $459.0K | $— | — |
| Q4 null | $27.5M | 90.8% | $2.9M | $-1.6M | $— | — |
| FY null | $103.1M | 90.1% | $9.1M | $-37.6M | $— | — |
| Q3 null | $26.3M | 90.6% | $3.0M | $-30.4M | $— | — |
| Q2 null | $25.8M | 92.5% | $-31.3K | $-2.0M | $— | — |
| Q1 null | $23.4M | 89.2% | $825.5K | $-3.5M | $— | — |
| Q4 null | $26.3M | 91.4% | $-374.9K | $-1.5M | $— | — |
| FY null | $86.7M | 90.6% | $-6.7M | $-9.7M | $— | — |
| Q3 null | $21.7M | 90.8% | $-1.9M | $-2.9M | $— | — |
| Q2 null | $20.2M | 90.0% | $-2.9M | $-3.5M | $— | — |
| Q1 null | $18.5M | 89.8% | $-1.5M | $-1.8M | $— | — |
| Q4 2023 | $17.7M | 89.9% | $-226.0K | $-237.2K | $-0.03 | — |